Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Chemokine signaling pathway | R-HSA-168638 | map04062 | clomifene | 1548955 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | clomifene | 1548955 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clomifene | 1548955 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | clomifene | 1548955 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | clomifene | 1548955 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | clomifene | 1548955 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | zoxazolamine | 8249 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | zoxazolamine | 8249 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | zoxazolamine | 8249 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | zoxazolamine | 8249 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | zoxazolamine | 8249 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | zoxazolamine | 8249 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | zoxazolamine | 8249 | drug-path |
| Asthma | R-HSA-444620 | map05310 | zoxazolamine | 8249 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | zoxazolamine | 8249 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | zoxazolamine | 8249 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | zoxazolamine | 8249 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | zoxazolamine | 8249 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | zoxazolamine | 8249 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | zoxazolamine | 8249 | drug-path |